Excision BioTherapeutics Appoints Former Pfizer Chairman and CEO Jeffrey B. Kindler to its Board of Directors

Agreement aims to explore commercial opportunities using NUBURU’s proprietary Blue Laser technology and GE Additive’s machine and system expertise, with the goal of continuing to improve speed and accuracy for laser-based additive manufacturing.

NUBURU and GE Additive Sign Joint Development Agreement

Agreement aims to explore commercial opportunities using NUBURU’s proprietary Blue Laser technology and GE Additive’s machine and system expertise, with the goal of continuing to improve speed and accuracy for laser-based additive manufacturing.